TY  - JOUR
AU  - Karachaliou, Niki
AU  - Fernandez-Bruno, Manuel
AU  - Rosell, Rafael
PY  - 2018
TI  - Strategies for first-line immunotherapy in squamous cell lung cancer: are combinations a game changer?
JF  - Translational Lung Cancer Research; Vol 7, Supplement 3 (September 26, 2018): Translational Lung Cancer Research1
Y2  - 2018
KW  - 
N2  - The initial treatment for metastatic squamous cell non-small cell lung cancer (NSCLC) consists of platinum-based combination chemotherapy. The most commonly used regimens are carboplatin and paclitaxel, carboplatin and protein-bound paclitaxel (nab-paclitaxel), and cisplatin and gemcitabine.
UR  - https://tlcr.amegroups.org/article/view/22760